CTOs on the Move

Pivot Bio

www.pivotbio.com

 
Founded in 2011, Pivot Bio is a sustainable agriculture company delivering farmers patented crop nutrition technologies that harness the power of nature to reliably and productively grow the food the world needs in the face of increasing volatility. Synthetic nitrogen is one of agriculture`s leading contributors to global greenhouse gas emissions. Our products are a breakthrough innovation and among the industry`s most promising climate solutions because they deliver nitrogen to plants without the negative impacts of synthetic fertilizer. Our nitrogen is weatherproof, safer to handle, does not leach or contribute to nitrous oxide pollution. By making this possible for the ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.pivotbio.com
  • 2910 Seventh Street
    Berkeley, CA USA 94710
  • Phone: 515.436.4462

Executives

Name Title Contact Details
John Walls
Chief Information Officer Profile

Funding

Pivot Bio raised $70M on 10/02/2018
Pivot Bio raised $100M on 04/30/2020

Similar Companies

Octave

Octave is a Nashua, NH-based company in the Software and Internet sector.

Avionyx

Avionyx is a Melbourne, FL-based company in the Software and Internet sector.

Material In Motion

Material In Motion is a Mountain View, CA-based company in the Software and Internet sector.

Solo.io

Solo is a trusted partner to hundreds of companies around the world. Our industry-leading service mesh and API management platform, Gloo Platform, enables companies to secure, scale, simplify, and save costs on their application networking. Solo.io creates solutions that allow companies to deliver modern applications faster, and across any cloud infrastructure. Our engineering teams are shaping the future of cloud native computing.

Vineti

Vineti is a company purpose-built for personalized therapies. From the beginning, Vineti`s founders have understood the challenges that biotech and pharmaceutical innovators face in developing personalized therapies. The emerging ecosystem of cell therapies, gene therapies, and personalized cancer vaccines requires new enabling technologies to align and manage production processes and the patient journey. Our patent pending Personalized Therapy Management (PTM) platform provides the next-generation technology that advanced therapies need.